- Brand names:
- Pharmaceutical Company:
- Condition/Indication: Dry eye disease in patients with keratitis
- Meeting Date: March 2021
- Public Summary Document (PSD) March 2021 PBAC Meeting - (PDF 1467KB)
- Public Summary Document (PSD) March 2021 PBAC Meeting - (Word 236KB)
Ciclosporin – March 2021
Ciclosporin: Eye drops 0.1%, single dose units 0.4 mL, 30; Ikervis®
Last updated
2 July 2021